Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia.
about
Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletionsThe ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stabilityDNA Methylation and Chromatin Remodeling: The Blueprint of Cancer EpigeneticsEarly Life Adverse Environmental Exposures Increase the Risk of Uterine Fibroid Development: Role of Epigenetic RegulationEpigenetic modulators, modifiers and mediators in cancer aetiology and progressionTargeting EZH2 in cancerHistone acetylation: novel target for the treatment of acute lymphoblastic leukemiaEZH2 in normal hematopoiesis and hematological malignanciesMutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomasMechanisms of epigenetic regulation of leukemia onset and progressionRedefining ALL classification: toward detecting high-risk ALL and implementing precision medicineChromatin targeting drugs in cancer and immunityMyeloid malignancies: mutations, models and managementFrom fly wings to targeted cancer therapies: a centennial for notch signalingChromatin signatures of cancerGain-of-function mutation of chromatin regulators as a tumorigenic mechanism and an opportunity for therapeutic interventionPolycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistance.Structural basis of histone H3K27 trimethylation by an active polycomb repressive complex 2The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL.Emerging concepts of epigenetic dysregulation in hematological malignanciesTargeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemiaThe methyltransferases enhancer of zeste homolog (EZH) 1 and EZH2 control hepatocyte homeostasis and regenerationControl of embryonic stem cell identity by BRD4-dependent transcriptional elongation of super-enhancer-associated pluripotency genesIncreasing Notch signaling antagonizes PRC2-mediated silencing to promote reprograming of germ cells into neuronsWeaver Syndrome-Associated EZH2 Protein Variants Show Impaired Histone Methyltransferase Function In VitroOccupying Chromatin: Polycomb Mechanisms for Getting to Genomic Targets, Stopping Transcriptional Traffic, and Staying PutChimeric RNAs generated by intergenic splicing in normal and cancer cells.EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent.Gene set control analysis predicts hematopoietic control mechanisms from genome-wide transcription factor binding data.Large-scale quality analysis of published ChIP-seq data.Epigenetic control of immunityEzh2 Acts as a Tumor Suppressor in Kras-driven Lung Adenocarcinoma.Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subsetGenome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia.Chromatin proteins and modifications as drug targets.Regulation and Role of EZH2 in CancerMaturation stage of T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL dependence and sensitivity to ABT-199A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells.EZH2 in normal and malignant hematopoiesis.MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia.
P2860
Q21261481-20A15214-837F-444A-A4B7-7EBF8ED395B2Q24296476-ACA3EAFB-5281-4A2A-9AF6-1E0C57CE715AQ26749421-DC4AF1C4-2BF7-48B1-A3C7-894DCAE14BCDQ26765991-EC22B4EF-05A9-4C01-8FB6-361765F7C039Q26766149-21B4224B-921C-41A3-9A3E-82698B68245DQ26769027-DAE8BE00-3CAC-4211-8E55-8F7647E759D4Q26778780-3E7C0865-9C3A-4DCB-9E4F-F96FA7CE0AB7Q26779821-9EE5AE84-04E1-4C56-B2CF-26FDD5541B5AQ26782506-4C0AA56F-1C72-4CA8-A01E-E80BDFC96A3AQ26861785-D0DFBE33-A3F8-4CB0-BC5A-B33E83ECF602Q26864460-713CC788-F525-449E-847B-631FDC069AFCQ26999888-2E8ED3E2-712E-463D-97F7-594350B59F31Q27000577-0C81FBB4-27F5-4977-A2E9-E132C24DE310Q27004534-C620987C-6B6C-4D97-B117-F6DDA425DC2CQ27024162-3AE7062D-09A7-473C-BC34-67500F529959Q27024233-AFC4024E-11DD-42F6-85AA-1F2E2044AA15Q27319398-701FC2A7-1367-42B0-AA17-EFE8A616210FQ27702306-738BBFA3-8774-44BF-A153-7AF514D081E8Q27852046-6480B0CE-036B-43FD-B577-747BFF3F451FQ28074522-5A58E2C5-44AB-451E-8565-17C02D5C4618Q28112138-F5EEF805-20FC-4805-B38F-8843A1663648Q28509576-A02CB711-50DF-4C15-99B9-30623333C7C2Q28650442-B4F85A68-E7E6-47BD-869B-33392204C55BQ28828201-63710798-7FFD-419C-BB7D-FF893C3DE3B9Q29147503-EF490FC5-1739-45DB-B60F-8305A2742E28Q29301233-8EBAD50C-3F96-4472-95D2-CB340BFD8074Q30458901-7C7AAEDB-31C5-4C01-9B42-14541BD4AF4FQ30538848-33D3BCC6-9DEE-453B-85F0-66CC12B1917BQ30580583-A599BD6D-63B4-4664-829B-590BC2FFE908Q30717456-DAB4B954-29B9-45E7-8401-E95D77CFEE4BQ33653705-A8DBF261-498D-4355-92F9-1EBBEAE15A7AQ33717790-CBA3DF6E-6849-4AE0-94CA-EFD146B71FC2Q33728277-0875D5AA-997C-4261-A927-4D282D575A5EQ34038562-70D7A2DA-057B-4BA3-8A10-18092748EE91Q34038652-C8DEA29F-9271-45E9-89F6-52A942CAFCF4Q34043370-82697302-72C2-40DB-A212-32D84674E0C8Q34135298-EA6A76C2-BFAF-4258-85F1-D4F537455E8BQ34302726-D7BB1749-C477-4A2C-B00F-D22DC681F093Q34375614-959C60E4-11C7-49BE-9B82-97883E2DF6C9Q34386922-6358DDB6-7D8C-4C79-9751-0CCE3F7B1C95
P2860
Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Genetic inactivation of the po ...... acute lymphoblastic leukemia.
@ast
Genetic inactivation of the po ...... acute lymphoblastic leukemia.
@en
type
label
Genetic inactivation of the po ...... acute lymphoblastic leukemia.
@ast
Genetic inactivation of the po ...... acute lymphoblastic leukemia.
@en
prefLabel
Genetic inactivation of the po ...... acute lymphoblastic leukemia.
@ast
Genetic inactivation of the po ...... acute lymphoblastic leukemia.
@en
P2093
P2860
P50
P356
P1433
P1476
Genetic inactivation of the po ...... acute lymphoblastic leukemia.
@en
P2093
Adolfo Ferrando
Dolors Ferres-Marco
Filippo Utro
Iannis Aifantis
Isaura Rigo
Jacob M Rowe
Janis Racevskis
Jasmin Siegle
Jelena Nedjic
P2860
P2888
P304
P356
10.1038/NM.2651
P407
P50
P577
2012-02-06T00:00:00Z